InsidersTradesSigma
申报总数
公司
▲ 买入（5 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
5
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Catelani Michael, 首席财务官. Officer active across 1 company, notably Anixa Biosciences Inc. In total, 12 reports have been published. Split: 5 buys · 0 sell. Total volume traded: €70k. History available since 30 April 2021. The latest transaction was filed on 15 January 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Catelani Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
9,289 股@ US$2.1520.4% 占其流量Common StockSEC:0001493152-25-002314:0
标准退出：2025年4月15日 (T+90)
6,250 股@ US$2.4014.5% 占其流量Common StockSEC:0001493152-24-023037:0
标准退出：2024年9月5日 (T+90)
1,189 股@ US$2.523.0% 占其流量Common StockSEC:0001493152-24-017496:0
1,117 股@ US$2.693.0% 占其流量Common StockSEC:0001493152-23-039093:0
5,500 股@ US$3.6419.0% 占其流量Common StockSEC:0001493152-23-025185:0
标准退出：2023年10月18日 (T+90)
865 股@ US$3.472.9% 占其流量Common StockSEC:0001493152-23-014890:0
1,069 股@ US$2.813.2% 占其流量Common StockSEC:0001493152-22-030070:0
1,086 股@ US$2.760.0030% mcap8.8% 占其流量Common StockSEC:0001493152-22-011741:0
5,500 股@ US$2.660.014% mcap41.8% 占其流量Common StockSEC:0001493152-22-010689:0
标准退出：2022年7月20日 (T+90)
2,509 股@ US$2.530.0062% mcap18.1% 占其流量Common StockSEC:0001493152-22-010594:0
标准退出：2022年7月19日 (T+90)
743 股@ US$4.042.9% 占其流量Common StockSEC:0001493152-21-026933:0
1,634 股@ US$1.842.8% 占其流量Common StockSEC:0001493152-21-010447:0
12 条申报中的 12 条
About Catelani Michael
Michael Catelani is the Chief Financial Officer and COO at Anixa Biosciences Inc. He is responsible for the financial management of the company, including financial planning, risk management, and financial reporting. His role is essential to ensure the financial health and sustainability of the organization. As President, he also contributes to the strategic direction of the company.
